Accordingly, the combination treatment increased tumor antigen-specific CD8+ T cells (Figure 8C), which produce multiple effector cytokines, such as IFN-γ and TNF-α (Figure 8D), in the dLNs and the TME. This evidence concerns the gene IFNG and neoplasm.